Close Menu
HomeNewsletterPurdue Pharma, Sacklers reach new $7.4 billion opiod settlement

Purdue Pharma, Sacklers reach new $7.4 billion opiod settlement

(NPR) “All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company’s improper marketing of opioids.

The deal was filed with a federal bankruptcy court by Purdue Pharma officials in March after negotiations with state attorneys general and other stakeholders. If this plan is finalized, payouts will occur over the next 15 years…

According to the company, a major change from past settlement deals will mean people who wish to sue the Sacklers in civil court for alleged wrong-doing will not be forced to give up those lawsuits.”

Share This Page:
Facebook Twitter LinkedIn